Peptides and Diabetic Neuropathy: Nerve Damage in Diabetes
Diabetic peripheral neuropathy affects up to 50% of diabetes patients and has no disease-modifying treatments. Research into BPC-157 and SS-31 explores vascular, anti-inflammatory, and mitochondrial protection mechanisms relevant to nerve damage in diabetes.
